Barrow, Hanley, Mewhinney & Strauss’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.4M Buy
440,131
+28,617
+7% +$4.14M 0.22% 101
2026
Q1
$48.6M Buy
411,514
+64,881
+19% +$8.51M 0.16% 107
2025
Q4
$41.2M Buy
346,633
+346,474
+217,908% +$39.5M 0.14% 112
2025
Q3
$15.9K Buy
+159
New +$18.9K ﹤0.01% 179
2017
Q1
– Sell
-10,317
Closed -$217K – 434
2016
Q4
$217K Sell
10,317
-22,764
-69% -$434K ﹤0.01% 336
2016
Q3
$573K Buy
+33,081
New +$544K ﹤0.01% 313

Other funds holding NOVT

Barrow, Hanley, Mewhinney & Strauss's NOVT Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Novanta (NOVT) stake by 7% in Q2 2026, buying an estimated $4.14M and bringing the position to 440,131 shares worth $71.4M. The position accounts for 0.22% of the portfolio, ranked #101.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NOVT in Q3 2016 and has held it in 6 quarters since. 391 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 440,131 shares of Novanta worth $71.4M as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 28,617 Novanta shares in Q2 2026, an estimated $4.14M.
  • Novanta made up 0.22% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #101 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Novanta in Q3 2016 and has held it in 6 quarters since.
  • 391 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.